SHREE GANESH REMEDIES   
                    
                    
                                                         
                                
                                                                 Back to All Ratios 
                                                
                     | 
                        
                        
                        
                        
                    
SHREE GANESH REMEDIES Last 5 Year Cash Profit Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Cash Profit Margin (%) | 29.30 | 26.46 | 19.94 | 20.60 | 
What is the latest Cash Profit Margin ratio of SHREE GANESH REMEDIES ?
| Year | Cash Profit Margin | 
|---|---|
| Mar2025 | 29.30 | 
| Mar2024 | 26.46 | 
| Mar2020 | 19.94 | 
| Mar2019 | 20.60 | 
How is Cash Profit Margin of SHREE GANESH REMEDIES Trending?
| Years | Cash Profit Margin | % Change | |
|---|---|---|---|
| Mar2025 | 29.3 | 10.73 | |
| Mar2024 | 26.46 | 32.70 | |
| Mar2020 | 19.94 | -3.20 | |
| Mar2019 | 20.6 | - | |
Other Financial Ratios of SHREE GANESH REMEDIES
| Operational &  Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate  | Margin  Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin  | Performance  Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales  | Efficiency  Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days  | Valuation  Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales  | Growth  Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth  | Financial Stability  Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap  | 
Compare Cash Profit Margin ratio of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹634.9 Cr | 1% | -3.5% | -34% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| SHREE GANESH REMEDIES |    1%  | 
                            
                     
                     -3.5%  | 
                     
                     -34%  | 
                    
| SENSEX |    -0.3%  |    
                      
                    
                     4.5%  | 
                     
                     5.7%  | 
                    
You may also like the below Video Courses